Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Reflect ScientificRSCF -9.62% Days Sales Outstanding is 48.93 as of Sep. 2025, which is 48% above its 10-year median of 33.04. The stock has 4 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Reflect Scientific ranks worse than 86.08% on this metric.
The historical rank and industry rank for Reflect Scientific's Days Sales Outstanding or its related term are showing as below:
RSCF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 27.27 Med: 33.04 Max: 125.42
Current: 125.42
During the past 13 years, Reflect Scientific's highest Days Sales Outstanding was 125.42. The lowest was 27.27. And the median was 33.04.
RSCF's Days Sales Outstanding is ranked worse than 86.08% of 812
companies
in the Medical Devices & Instruments industry
Industry Median: 65.165
vs RSCF: 125.42
Reflect Scientific's Days Sales Outstanding
increased
from Mar. 2024 (47.11) to Sep. 2025 (48.93).
Reflect Scientific (OTCPK:RSCF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Reflect Scientific Days Sales Outstanding Related Terms
Reflect Scientific Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Reflect Scientific's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RSCF vs NXGL, YBGJ, GCTK: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, Reflect Scientific's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's Days Sales Outstanding falls into.
Reflect Scientific Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Reflect Scientific (RSCF) has a Days Sales Outstanding of 48.93 as of Sep. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Reflect Scientific and its competitors. This is 48% above median its historical median of 33.04. Over the past decade, Reflect Scientific's Days Sales Outstanding has ranged from 27.27 to 125.42. According to the industry distribution chart, Reflect Scientific ranks #699 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 86.1%.
Is Reflect Scientific's Days Sales Outstanding too high?
Reflect Scientific's current Days Sales Outstanding of 48.93 is 48% above median its 10-year median of 33.04. Over the past 10 years, this metric has ranged from a low of 27.27 to a high of 125.42. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.17. Reflect Scientific's value of 48.93 is 24.9% below this industry median. Based on the distribution chart, Reflect Scientific ranks #699 out of 812 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Reflect Scientific's Days Sales Outstanding compare to NXGL and YBGJ?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #699 out of 812 companies for Days Sales Outstanding. This places Reflect Scientific in the lower half of its industry. The industry median Days Sales Outstanding is 65.17. Reflect Scientific's value of 48.93 is 24.9% below this benchmark. Historically, Reflect Scientific's own Days Sales Outstanding has ranged from 27.27 to 125.42 over the past decade. While the company's 10-year median is 33.04 vs. the industry median of 65.17, Reflect Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.17, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current Days Sales Outstanding of 48.93 is 24.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Reflect Scientific and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current Days Sales Outstanding is 48.93, which is 48% above median its own 10-year median of 33.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current Days Sales Outstanding of 48.93. The current Days Sales Outstanding is 48.93, which is 48% above median its 10-year median of 33.04 and 24.9% below the Medical Devices & Instruments industry median of 65.17. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current Days Sales Outstanding is 48.93 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 
